July 16, 2024
Loading...
You are here:  Home  >  Health Care & Life Science  -  Page 132
Latest

Inogen’s profits just keep on growing

By   /  Tuesday, May 9th, 2017  /  Earnings, Health Care & Life Science, Latest news, South Coast, Technology, Tri-County Public Companies  /  Comments Off on Inogen’s profits just keep on growing

Goleta-based Inogen, an oxygen concentrator company, reported a $5.9 million profit for the first quarter of 2017, up from $2.5 million in the first quarter of 2016, according to an earnings report May 9. The company reported $52.5 million in revenue, up 22.1 percent from the same period in 2016. Sales revenue was at $46 Read More →

Latest

Sientra narrows losses in first quarter report

By   /  Tuesday, May 9th, 2017  /  Earnings, Health Care & Life Science, Latest news, South Coast, Technology, Tri-County Public Companies  /  Comments Off on Sientra narrows losses in first quarter report

Goleta-based breast implant company Sientra continued to cut its losses, losing $11.4 million in the first quarter of 2017, down from $11.9 million for the same period the year prior. “I am pleased with our first quarter performance, which was in line or above our expectations,” said Jeffrey Nugent, chairman and CEO. “In the first Read More →

Latest

MindBody revenue soars but net loss continues

By   /  Thursday, May 4th, 2017  /  Earnings, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on MindBody revenue soars but net loss continues

San Luis Obispo-based MindBody reported $42.2 million in first quarter revenue, a 32 percent increase from a year ago during the same period, but the company still reported a net loss. The GAAP net loss in the first quarter of 2017 was $3.9 million, down from $6.6 million during the first quarter of 2016. The Read More →

Latest

Amgen to provide rebates for Repatha patients who have heart attack or stroke

By   /  Tuesday, May 2nd, 2017  /  Health Care & Life Science, Latest news  /  Comments Off on Amgen to provide rebates for Repatha patients who have heart attack or stroke

Thousand Oaks-based Amgen announced on May 2 that it has reached a “first-of-its-kind contract” with health care company Harvard Pilgrim. The contract provides Harvard Pilgrim with a rebate for the cost of Repatha for any eligible patient who has a heart attack or stroke while on Repatha. “Amgen is committed to combating cardiovascular disease, one Read More →

Latest

Amgen revenues fall but profits increase

By   /  Wednesday, April 26th, 2017  /  Earnings, East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen revenues fall but profits increase

Thousand Oaks-based biotech giant Amgen’s total revenues decreased by 1 percent to $5.5 billion during the first quarter of 2017, compared to the same period a year ago, according to an earnings report April 26. The drop was related to the plunge in sales of Enbrel, its rheumatoid arthritis drug. Sales decreased 15 percent due Read More →

Latest

Cottage Health settles flesh-eating disease death lawsuit

By   /  Friday, April 7th, 2017  /  Columns, Health Care & Life Science, Latest news, Law & Goverment  /  Comments Off on Cottage Health settles flesh-eating disease death lawsuit

Cottage Hospital wants to merge with Sansum Clinic. Regulators are studying the proposal. (Nik Blaskovich)

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Thousand Oaks braces for Amgen staff cuts

By   /  Friday, March 31st, 2017  /  East Ventura County, Health Care & Life Science, Technology, Top Stories, Top Story  /  Comments Off on Thousand Oaks braces for Amgen staff cuts

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.